pre-update Archives

Blog

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…

Certara2021年6月25日

Article

Fundamentals of regulatory writing: the document development process

Regulatory writers lead the development of high-quality regulatory documents by working incollaboration with colleagues across…

Certara2021年6月22日

Blog

Simcyp PBPK Simulatorをお客様の医薬品開発プログラムに統合する10のメリット

Per US FDA’s recent paper on the topic, Physiologically based Pharmacokinetic (PBPK) modeling & simulation…

Certara2021年6月22日

Blog

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…

Certara2021年6月18日

Blog

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

Every FDA Advisory Committee meeting is unique, and the Cellular, Tissue, and Gene Therapies Advisory…

Certara2021年6月15日

Brochure

ベンチから市場へ、インパクトのあるサイエンスを推進

Learn how Certara drives impactful science.

Certara2021年6月14日

On-Demand Webinar

Three Pathways have emerged in Innovative Access Agreements

The days of simply determining the market demand for a new drug as a function…

Certara2021年6月11日

On-Demand Webinar

Outcomes Based Agreements

The days of simply determining the market demand for a new drug as a function…

Certara2021年6月11日

Press Release

Certara Acquires UK-based Insight Medical Writing

Expands global reach and deepens regulatory expertise PRINCETON, NJ.— 2021年6月10日– Certara, Inc., the…

Certara2021年6月10日

Video

Your First Choice in Complex Biologics Drug Development

The pharmaceutical has made massive investments in complex biologics, a drug class that includes oligonucleotide…

Certara2021年6月1日

pre-update

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

Fundamentals of regulatory writing: the document development process

Simcyp PBPK Simulatorをお客様の医薬品開発プログラムに統合する10のメリット

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

ベンチから市場へ、インパクトのあるサイエンスを推進

Three Pathways have emerged in Innovative Access Agreements

Outcomes Based Agreements

Certara Acquires UK-based Insight Medical Writing

Your First Choice in Complex Biologics Drug Development

メルマガ登録

クイックアクセス

ソリューション

お問合せ